Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Sample input vs genome length or both?

    Hellos group,

    I have a technical question, I'm working with a viral (surprise!) genome. It is approx 200kbp in length and is a DNA virus. We will be sequencing this on the Ion PGM and I have a question about library prep.

    We will be using the enzymatic shearing protocol which is optimized for e.coli which is 4.6 - 5.6 Mbp so I need to optimize the shear times. So my question is which is the more important factor to start tweaking, the amount of time spent in the reaction or the amount of enzyme used?

    Has anyone had any experience with this type of question I would like to know some of the pitfalls before I start burning through sample preps like a mad man.

  • #2
    Is the enzymatic fragmentation done with transposomes or "randomly" cutting dsDNA endonucleases?

    I'd imagine the enzyme concentration having a higher impact than adjusting incubation times. See these two dsDNA shearases:
    Science made simple. Zymo Research provides products and services for molecular and cellular biology, Epigenetics and Microbiomics research. Try free sample kits today.



    Not sure what the difference between the "plus" and the "normal" version is (probably old and newer version), but in the "plus" one the sheared DNA exhibits clearer shifts with increasing units of enzyme added. Although that makes the price per reaction also higher.

    We also had this optimization in our lab, but I can't find the gel picture atm.

    Although these reactions are mostly optimized on humans or E.coli as you say, the DNA it is usually tested on is rarely bigger than the size of your intact viral genome. This heavily depends on the DNA prep. I wouldn't expect a drastically different shearing outcome...

    Comment


    • #3
      Thank you lorendarith,

      These links are helpful and will give me a narrow window to try

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Understanding Genetic Influence on Infectious Disease
        by seqadmin




        During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

        Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
        09-09-2024, 10:59 AM
      • seqadmin
        Addressing Off-Target Effects in CRISPR Technologies
        by seqadmin






        The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
        08-27-2024, 04:44 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, Today, 06:25 AM
      0 responses
      12 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, Yesterday, 01:02 PM
      0 responses
      11 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-18-2024, 06:39 AM
      0 responses
      13 views
      0 likes
      Last Post seqadmin  
      Started by seqadmin, 09-11-2024, 02:44 PM
      0 responses
      14 views
      0 likes
      Last Post seqadmin  
      Working...
      X